ArticleJournal of the American College of Clinical Pharmacy : JACCP2024
A qualitative study exploring patient experiences and opinions of warfarin patient self-management in the US healthcare system.
Article in Journal of the American College of Clinical Pharmacy : JACCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical Trial.JAMA network open · 2026Trial
- Self-testing and clinical outcomes in Black and White patients on warfarin for atrial fibrillation or venous thromboembolism.Research and practice in thrombosis and haemostasis · 2026Observational
- Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study Protocol.medRxiv : the preprint server for health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Despite consensus guideline recommendations, the use of warfarin patient self-management (PSM) in the United States (US) healthcare system remains underutilized. Objectives: To gain an understanding of the barriers and facilitators to warfarin PSM in US healthcare systems through qualitative exploration of the opinions of select US patients receiving warfarin therapy. Methods: Individual patient interviews were conducted at five geographically diverse sites. Grounded theory analysis was performed on interview transcriptions using the consolidated framework for implementation research (CFIR) to identify facilitators and barriers to PSM implementation within the US healthcare system. Results: A total of 40 patients were interviewed. Four major themes emerged from the interviews: (1) "Patients are resourceful problem solvers who know themselves better than clinicians" (CFIR domain "Characteristics of Individuals"); (2) The provider-patient relationship is key to successful PSM (CFIR domains "Inner Setting" and "Intervention Characteristics"); (3) Patients are willing and interested in trying PSM if not already doing so (CFIR domains "Process," "Intervention Characteristics," "Inner Setting, and "Characteristics of Individuals"); and (4) Point-of-care international normalized ratio (INR) monitoring is an important PSM facilitator (CFIR "Intervention Characteristics," "Outer Setting," "Inner Setting," and "Process" domains). Conclusions: Interview participants were willing and interested in trying PSM. Core elements of warfarin PSM include timely access to INR results, and a framework to support PSM decision making. Home INR monitoring is likely ideal for facilitating PSM implementation as is maintaining strong provider-patient relationships where providers, including clinical pharmacists, trust their patients and act as a safety net for PSM decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.